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A large green and brown frog may help
researchers define the pathway that leads to the
development of the inner ear. Dr. Jean-Pierre
Saint-Jean-
net, assis-
tant pro-
fessor of
develop-
mental
biology at
the School,
has worked
for many years with the South African frog,
Xenopus laevis, in his studies on neural crest
cells formation. These cells are an important
cell type of the body as they give rise to all
bones and cartilage of the face, pigment cells,
and most of the peripheral nervous system.
Current studies in his laboratory focus on
Sox9 and Sox10, two members of a family of
transcription factors involved in cell determi-
nation. When embryonic cells develop into the
specialized cell types of the body, Sox proteins
interact with the DNA and activate specific dif-
ferentiation
program. Like
most transcrip-
tion factors,
they are, in
essence, the
switches that
turn on genes,
that encode a
specific repertoire of proteins, signature of each
cell types. It is thought that humans have about
1,000 different transcription factors.
“In recent years, a number of transcription
factors that show restricted expression pattern
in the developing inner ear, have been shown
to play a major role in the specification and
patterning of the auditory system,” explains
Saint-Jeannet. “We believe that Sox proteins are
also part of that process.”
Saint-Jeannet and his colleagues have
shown that Sox9 and Sox10 are expressed very
early in the progenitors that give rise to the
inner ear. If the Sox9 gene is removed from the
early frog embryo, the development of the ear
is severely disturbed. The goal of these studies
is to determine during which phase of the
development of the inner ear Sox9 and Sox10
are essential. Saint-Jeannet thinks that it is very
early in the process. In humans it has been
shown that mutations in Sox9 and Sox10 genes
result in severe pathologies characterized by a
number of developmental defects, including
deafness.
These studies, sponsored by the Deafness
Research Foundation, hope to better define the
processes involved in inner ear formation and
therefore improve our understanding of the
numerous pathologies associated with the
auditory system.
Frogs point to pathway for inner ear development
Scientists find a gene that’s key to cloning success
By Stephen Bradt
A team led by K. John McLaughlin and
Hans R. Schöler at the School has found that
the activity of a single gene is a powerful pre-
dictor of whether newly cloned mammalian
embryos will survive and thrive, but the gene’s
sporadic expression in cloned mouse embryos
casts fresh doubt on prospects for reproductive
human cloning.
Despite the successful cloning of sheep, pigs
and cats, mammalian cloning—in which an
ordinary cell's nucleus is transferred to an egg
whose nucleus has been removed—remains
remarkably inefficient. Fewer than three in 100
cloned mouse embryos survive to birth.
McLaughlin and Schöler’s groups showed
that the activity of the gene Oct4 correlates
strongly with the viability of cloned embryos
but also found that in only one-tenth of cloned
mouse embryos is the gene expressed at the
right level in the right place at the right time.
Without Oct4, embryos cannot survive; even if
Oct4 expression is a tad high or low, an embryo
will die.
“Cloning requires the precise reprogram-
ming of the nucleus inserted into an enucleated
egg,” said Schöler, professor of animal biology
and director of Penn's Center for Animal
Transgenesis and Germ Cell Research. “This
nucleus must abandon its former genetic pro-
gram and adopt the genetic profile of an
embryonic nucleus; failure to do so dooms the
embryo.”
To evaluate the accuracy of this genetic
reprogramming, the Penn group analyzed Oct4
expression in cloned mouse embryos derived
from cells that surround ovulated eggs in adult
mice, cells that would not normally express
Oct4. The result: Only 34 percent of embryonic
cells correctly reprogrammed to express Oct4,
and just 10 percent showed levels of Oct 4
expression conducive to further development.
Even as it suggests new hurdles for repro-
ductive human cloning, the Penn work offers
new support for the feasibility of therapeutic
cloning using embryonic stem cells.
“The small number of clones that did ade-
quately express Oct4 were capable of forming
embryonic stem cell lines,” Schöler said, “sup-
porting existing evidence of the scientific feasi-
bility of therapeutic cloning even as it shows
the infeasibility of reproductive human
cloning.”
The Penn team chose Oct4 as a marker
because its expression is tightly regulated
throughout the mammalian life cycle. Oct4,
which encodes a protein critical to normal
embryonic development, is expressed only in
the portion of the embryo that eventually gives
rise to fetal tissues; in the adult, Oct4 is
expressed only in germ cells.
Although improper expression of Oct4 can
single-handedly obstruct embryonic develop-
ment, Oct4 is likely not the only gene expressed
incorrectly in cloned embryos.
“When we started the study, we thought
Oct4 misexpression might account for a frac-
tion of clone failures,” Schöler said. “The big
surprise was that Oct4 alone can explain most
of the failures, although Oct4 is probably just
one gene of many whose misexpression can
cause cloned embryos to fail.”
The research team was a combined effort of
the laboratories of McLaughlin and Schöler,
both faculty in the School’s Department of
Animal Biology, with major efforts from post-
doctoral researchers Michele Boiani and Sigrid
Eckardt, all part of the Center for Animal
Transgenesis and Germ Cell Research at Penn’s
School of Veterinary Medicine. Their work is
supported by the Marion Dilley and David
George Jones Funds and the Commonwealth
and General Assembly of Pennsylvania.
